Getting involved in wound care can be a very rewarding clinical niche. Many medical practitioners have limited experience and training in treating wounds, so when pharmacists have knowledge and compounded options to share, it is usually greatly appreciated. Understanding the pathophysiology of wounds and the pharmacology of the active pharmaceutical ingredients (APIs) used in wound treatment are needed to interact with prescribers and to formulate a patient-specific compound.

EctoSeal P2G, our revolutionary powder-to-hydrogel base, is the first natural, biodegradable polymer base created for wound care preparations. Read about the motivation behind its development, as well as clinical applications, from PCCA Clinical Compounding Pharmacist Mark Gonzalez, PharmD.

Beau Harger discusses some of the opportunities that pharmacy compounders have to help patients struggling with seasonal health challenges.

Nat Jones, one of PCCA's Clinical Compounding Pharmacist, discusses the importance of naltrexone and how compounders can use Low-Dose Naltrexone therapy, especially with dermatological health challenges.

Nat Jones drops in to provide compounding tips, preventative measures, and addressing various symptoms that compounding pharmacies can use when assisting patients with health challenges typically associated with fall and winter.

Jane Jones discusses "maskne", a new medical condition becoming more pervasive due to the repetitive use of facial masks. Jane talks about prevention and treatments that can potentially alleviate symptoms using compounded medications.

The winter season is often accompanied by health challenges. The cold air can contribute to various skin conditions, and it can dampen the immune system, leading to illness as well. Over the years, we have published some great information on compounding for this season in our members-only magazine, the Apothagram, so we decided to share some of that information in our latest blog post!

Periorbital hyperpigmentation is caused by various external and internal factors, which makes it very complex to treat, but PCCA's Sara Hover, RPh, FAARM, discusses treatment options unique to personalized medicine that may help compounding pharmacies treat patients with this skin disorder.

A great base for dermatological and cosmeceutical compounding requires certain qualities. For compounding pharmacies who need an anhydrous base that does the most, let us tell you about W06 and what it can do for your patients.